Reported Standalone quarterly numbers for Krebs Biochemicals & Industries are:
Net Sales at Rs 11.97 crore in March 2024 up 4.47% from Rs. 11.46 crore in March 2023.
Story continues below Advertisement
Quarterly Net Loss at Rs. 5.85 crore in March 2024 up 15.75% from Rs. 6.94 crore in March 2023.
EBITDA stands negative at Rs. 2.91 crore in March 2024 up 34.31% from Rs. 4.43 crore in March 2023.
Krebs Biochem shares closed at 68.55 on May 21, 2024 (BSE) and has given -12.64% returns over the last 6 months and 5.80% over the last 12 months.
Story continues below Advertisement
| Krebs Biochemicals & Industries | | Standalone Quarterly Results | in Rs. Cr. |
|
| Mar'24 | Dec'23 | Mar'23 | | Net Sales/Income from operations | 11.97 | 12.98 | 11.46 | | Other Operating Income | -- | -- | -- | | Total Income From Operations | 11.97 | 12.98 | 11.46 | | EXPENDITURE | | Consumption of Raw Materials | 1.81 | 1.03 | 0.31 | | Purchase of Traded Goods | 0.09 | -- | 0.04 | | Increase/Decrease in Stocks | 1.00 | 0.25 | 2.80 | | Power & Fuel | -- | -- | -- | | Employees Cost | 3.88 | 4.44 | 4.51 | | Depreciation | 1.67 | 1.73 | 1.48 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 8.32 | 9.35 | 8.43 | | P/L Before Other Inc. , Int., Excpt. Items & Tax | -4.79 | -3.82 | -6.10 | | Other Income | 0.21 | 0.03 | 0.19 | | P/L Before Int., Excpt. Items & Tax | -4.58 | -3.79 | -5.91 | | Interest | 1.27 | 1.19 | 1.03 | | P/L Before Exceptional Items & Tax | -5.85 | -4.98 | -6.94 | | Exceptional Items | -- | -- | -- | | P/L Before Tax | -5.85 | -4.98 | -6.94 | | Tax | -- | -- | -- | | P/L After Tax from Ordinary Activities | -5.85 | -4.98 | -6.94 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | -5.85 | -4.98 | -6.94 | | Equity Share Capital | 21.56 | 21.56 | 21.56 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | -2.72 | -2.31 | -3.07 | | Diluted EPS | -2.72 | -2.31 | -3.07 | | EPS After Extra Ordinary | | Basic EPS | -2.72 | -2.31 | -3.07 | | Diluted EPS | -2.72 | -2.31 | -3.07 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
